We are live on ! Find out more
CVS icon

CVS Health
CVS

1,779 hedge funds and large institutions have $69.2B invested in CVS Health in 2018 Q4 according to their latest regulatory filings, with 300 funds opening new positions, 896 increasing their positions, 486 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more first-time investments, than exits

New positions opened: 300 | Existing positions closed: 102

84% more repeat investments, than reductions

Existing positions increased: 896 | Existing positions reduced: 486

46% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $775M

11% more funds holding

Funds holding: 1,599 → 1,779 (+180)

5% more funds holding in top 10

Funds holding in top 10: 79 → 83 (+4)

1% more capital invested

Capital invested by funds: $68.8B → $69.2B (+$379M)

3.78% less ownership

Funds ownership: 85.94% → 82.16% (-3.8%)

Holders
1,779
Holders Change
+180
Holders Change %
+11.26%
% of All Funds
39.64%
Holding in Top 10
83
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+5.06%
% of All Funds
1.85%
New
300
Increased
896
Reduced
486
Closed
102
Calls
$1.13B
Puts
$775M
Net Calls
+$359M
Net Calls Change
+$126M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.82B
2
BlackRock
BlackRock
New York
+$1.25B
3
State Street
State Street
Massachusetts
+$1.25B
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$846M
5
Capital International Investors
Capital International Investors
California
+$704M

Top Sellers

Rank Fund Capital Flow
1
AIG
American International Group
New York
-$433M
2
Parnassus Investments
Parnassus Investments
California
-$200M
3
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$94.6M
4
Harris Associates
Harris Associates
Illinois
-$93.3M
5
N
Natixis
France
-$91.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$664M +$83M +1,111,929 +12%
Macquarie Group
27
Macquarie Group
Australia
$658M -$5.01M -67,093 -0.7%
TCIM
28
TIAA CREF Investment Management
New York
$564M +$166M +2,226,239 +35%
GCM
29
Glenview Capital Management
New York
$556M +$140M +1,875,037 +28%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$511M +$98.1M +1,314,338 +20%
Goldman Sachs
31
Goldman Sachs
New York
$497M +$170M +2,274,790 +43%
Legal & General Group
32
Legal & General Group
United Kingdom
$479M +$125M +1,677,859 +30%
Deutsche Bank
33
Deutsche Bank
Germany
$455M +$140M +1,871,024 +37%
Caisse de Depot et Placement du Quebec (CDPQ)
34
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$390M +$66.5M +891,161 +18%
Ameriprise
35
Ameriprise
Minnesota
$375M +$88.7M +1,187,965 +26%
UBS AM
36
UBS AM
Illinois
$364M +$133M +1,785,953 +47%
PPA
37
Parametric Portfolio Associates
Washington
$360M +$89.3M +1,196,326 +28%
Diamond Hill Capital Management
38
Diamond Hill Capital Management
Ohio
$341M +$195M +2,610,380 +100%
Barclays
39
Barclays
United Kingdom
$338M +$205M +2,749,259 +114%
Neuberger Berman Group
40
Neuberger Berman Group
New York
$334M +$99.5M +1,332,499 +35%
VVP
41
Vulcan Value Partners
Alabama
$333M -$54.8M -734,563 -13%
Sumitomo Mitsui Trust Group
42
Sumitomo Mitsui Trust Group
Japan
$324M +$122M +1,640,041 +49%
UBS Group
43
UBS Group
Switzerland
$307M +$48M +643,514 +16%
Primecap Management
44
Primecap Management
California
$295M +$62.7M +839,402 +23%
Swiss National Bank
45
Swiss National Bank
Switzerland
$291M +$85.5M +1,145,393 +35%
Allianz Asset Management
46
Allianz Asset Management
Germany
$287M +$57.9M +775,367 +21%
Fidelity International
47
Fidelity International
Bermuda
$283M +$162M +2,167,445 +100%
EIP
48
Epoch Investment Partners
New York
$254M +$275M +3,679,925 +1,909%
Millennium Management
49
Millennium Management
New York
$253M +$247M +3,303,892 +595%
Skandinaviska Enskilda Banken (SEB)
50
Skandinaviska Enskilda Banken (SEB)
Sweden
$246M -$9.54M -127,781 -3%
1
2
3 4 5

CVS Hedge Fund Activity: Q4 2018 in Review

1,779 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2018, worth a combined $69.2B — up 0.55% from $68.8B a quarter earlier.

Buyers outnumbered sellers: 300 funds opened new CVS positions and 102 closed out — a net gain of 198 holders — while 896 added to existing stakes and 486 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.82B. The largest seller was American International Group, cutting an estimated $433M.

  • 1,779 institutional investors held CVS Health (CVS) as of Q4 2018, up from 1,599 in Q3 2018.
  • Funds reported $69.2B of CVS Health stock for Q4 2018, up 0.55% quarter-over-quarter.
  • 300 funds opened new CVS Health positions in Q4 2018 and 102 closed out, a net change of +198 holders.
  • The largest CVS Health buyer in Q4 2018 was Vanguard Group, an estimated $1.82B added.
  • The largest CVS Health seller in Q4 2018 was American International Group, an estimated $433M sold.

Based on aggregated 13F filings for Q4 2018.